Authors: Neamati, N Marchand, C Winslow, HE Pommier, Y

Citation: N. Neamati et al., Human immunodeficiency virus type 1 integrase-targeted inhibitor design, ANTIRETROVIRAL THERAPY, 2001, pp. 87-104

Authors: Wang, YX Neamati, N Jacob, J Palmer, I Stahl, SJ Kaufman, JD Huang, PL Huang, PL Winslow, HE Pommier, Y Wingfield, PT Lee-Huang, S Bax, A Torchia, DA

Citation: Yx. Wang et al., Solution structure of anti-HIV-1 and anti-tumor protein MAP30: Structural insights into its multiple functions, CELL, 99(4), 1999, pp. 433-442

Authors: Neamati, N Turpin, JA Winslow, HE Christensen, JL Williamson, K Orr, A Rice, WG Pommier, Y Garofalo, A Brizzi, A Campiani, G Fiorini, I Nacci, V

Citation: N. Neamati et al., Thiazolothiazepine inhibitors of HIV-1 integrase, J MED CHEM, 42(17), 1999, pp. 3334-3341

Authors: Hong, H Neamati, N Winslow, HE Christensen, JL Orr, A Pommier, Y Milne, GWA

Citation: H. Hong et al., Identification of HIV-1 integrase inhibitors based on a four-point pharmacophore, ANTIVIR CHE, 9(6), 1998, pp. 461-472